RE:RE:RE:RE:Shelf prospectus When I invision a jv . I see a partnership where a credible pharmauctical that has been looking at getting into that potentially lucrative Alzheimers s treatment , but just can't quite pull the trigger on going all in. The hesitation could be the constant failures that have taken their toll of numerous companies over the past 20 years. Get involved by sharing the costs of the clinical with PMN and have the first hand info on how well the drug is or isnt working. They would have an advantage over other large companies who have to basically wait for the data on the clinicals to come out in the traditional way. I would assume that the jv partner would have a first right of refusal in their agreement with PMN. If this drug works as good as PMN scientists are claiming , it would indeed be best in class and worth billions of dollars. Our of partner would basically buy PMN out ( money we can not imagine right now) even before the clinicals are completed..because realistically PMN does not want to be in the drug manufacturing and distribution ..and historically small biotech will be eaten up by the huge monster pharmas if they have something these guys want their hands on.Thats my dream big scenario that has been with me for many years.